cn01 Search Results


calpeptin calp  (Cytoskeleton Inc)
95
Cytoskeleton Inc calpeptin calp
Calpeptin Calp, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/calpeptin calp/product/Cytoskeleton Inc
Average 95 stars, based on 1 article reviews
calpeptin calp - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
manual micromanipulator  (Cambridge NeuroTech)
90
Cambridge NeuroTech manual micromanipulator
Manual Micromanipulator, supplied by Cambridge NeuroTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/manual micromanipulator/product/Cambridge NeuroTech
Average 90 stars, based on 1 article reviews
manual micromanipulator - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
rhoii activator  (Cytoskeleton Inc)
90
Cytoskeleton Inc rhoii activator
Regulation of TAZ import by RhoA. a Effect of the RhoA activator <t>RhoII</t> on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase <t>inhibitor</t> <t>okadaic</t> acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test
Rhoii Activator, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhoii activator/product/Cytoskeleton Inc
Average 90 stars, based on 1 article reviews
rhoii activator - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
trimmed illumina sequences cn01  (Illumina Inc)
90
Illumina Inc trimmed illumina sequences cn01
Regulation of TAZ import by RhoA. a Effect of the RhoA activator <t>RhoII</t> on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase <t>inhibitor</t> <t>okadaic</t> acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test
Trimmed Illumina Sequences Cn01, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trimmed illumina sequences cn01/product/Illumina Inc
Average 90 stars, based on 1 article reviews
trimmed illumina sequences cn01 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cn01  (Cytoskeleton Inc)
93
Cytoskeleton Inc cn01
Regulation of TAZ import by RhoA. a Effect of the RhoA activator <t>RhoII</t> on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase <t>inhibitor</t> <t>okadaic</t> acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test
Cn01, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cn01/product/Cytoskeleton Inc
Average 93 stars, based on 1 article reviews
cn01 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
core cn-01  (Tanabe)
90
Tanabe core cn-01
Regulation of TAZ import by RhoA. a Effect of the RhoA activator <t>RhoII</t> on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase <t>inhibitor</t> <t>okadaic</t> acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test
Core Cn 01, supplied by Tanabe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/core cn-01/product/Tanabe
Average 90 stars, based on 1 article reviews
core cn-01 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Regulation of TAZ import by RhoA. a Effect of the RhoA activator RhoII on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase inhibitor okadaic acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test

Journal: Nature Communications

Article Title: Mediated nuclear import and export of TAZ and the underlying molecular requirements

doi: 10.1038/s41467-018-07450-0

Figure Lengend Snippet: Regulation of TAZ import by RhoA. a Effect of the RhoA activator RhoII on the nuclear enrichment of 1C-TAZ 4SA F52A (anchorless construct), n = 3. b Nuclear enrichment of 5C-TAZ 4SA upon RhoA activation by RhoII or by co-expression of constitutively active RhoA Q63L along with 2h LMB treatment, n = 6. c RhoA activation increases LMB-induced nuclear accumulation of 5C-TAZ 4SA. LMB time course without and with RhoA stimulation, n = 3. d RhoA activation increase LMB-induced nuclear accumulation of the 5C-TAZ-NLS. LMB time course without and with RhoA stimulation, n = 3. Rel. nuc./cyto. ratio refers to the difference between 5C-TAZ-NLS and 5C. Curves in c and d are fits as in Fig. . e RhoA activity selectively increases nuclear accumulation of the TAZ-NLS. 5C-290–345 and the SV40-NLS construct 5C-R5A were expressed in combination with control vector or RhoA Q63L. Following a 2 h treatment with or without LMB, nuclear accumulation was visually determined, n = 3, 5, or 6 for individual constructs. f RhoA stimulation does not induce LATS-independent TAZ phosphorylation, as detected by band shifts in western blots. Cells expressing 1C-TAZ 4SA were treated with PBS, RhoII or the phosphatase inhibitor okadaic acid (OA) for 6 h and lysates were run on conventional (upper panel) and Phos-tag (lower panel) polyacrylamide gels. After western blot, ectopic proteins were detected with anti-GFP antibody. Uncropped version shown in Supplementary Figure 6 . Data are represented as means ± SD. * p < 0.05, ** p < 0.01; Student’s t -test

Article Snippet: Leptomycin B, Rapamycin, and okadaic acid were purchased from Sigma Aldrich and RhoII activator from Cytoskeleton Inc. Phos-tag gels (Wako Pure Chemical Industries, Ltd.) were ordered from Cedarlane.

Techniques: Construct, Activation Assay, Expressing, Activity Assay, Plasmid Preparation, Western Blot